Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001554795-16-000582
Filing Date
2016-03-23
Accepted
2016-03-23 12:09:46
Documents
39
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K skin0317form10k.htm 10-K 260979
2 EXHIBIT 31.1 skin0317form10kexh31_1.htm EX-31.1 8242
3 EXHIBIT 31.2 skin0317form10kexh31_2.htm EX-31.2 8254
4 EXHIBIT 32.1 skin0317form10kexh32_1.htm EX-32.1 5463
  Complete submission text file 0001554795-16-000582.txt   1045487

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE skin-20151231.xml EX-101.INS 85362
6 XBRL SCHEMA FILE skin-20151231.xsd EX-101.SCH 13065
7 XBRL CALCULATION FILE skin-20151231_cal.xml EX-101.CAL 23287
8 XBRL DEFINITION FILE skin-20151231_def.xml EX-101.DEF 14456
9 XBRL LABEL FILE skin-20151231_lab.xml EX-101.LAB 91428
10 XBRL PRESENTATION FILE skin-20151231_pre.xml EX-101.PRE 71856
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30991 | Film No.: 161523236
SIC: 6770 Blank Checks